Maternal embryonic leucine zipper kinase (MELK) belongs to a group of serine/threonine kinases that physiologically modulates organogenesis during the embryonic period; however, its overexpression leads to the progression of many cancers, including GBM, majorly via activating transcription factors such as FOXM1 [44]. The gene discussed is MELK; the disease is glioblastoma.